San Francisco Chronicle

S.F. drug prices outpace nation’s

Prescripti­on charges way above average, study says

- By Catherine Ho

When Christina Hale ducked into a CVS on San Francisco’s Market Street on Thursday to pick up a prescripti­on she’d accidental­ly left at home in Indianapol­is, the price tag came as a surprise.

Hale, who was in town on business, usually pays $10 for a monthlong supply of the medication. But at the San Francisco pharmacy, she was charged $11.99 for just a five-day supply.

Hale isn’t sure why her medication cost as much as it did in San Francisco — she surmised it could’ve been because her insurance had already helped cover the previous supply — but said the lack of transparen­cy was troubling.

“It’s frustratin­g that as a patient away from home who needs medicine there’s a lack of transparen­cy and consistenc­y,” said Hale, a former state lawmaker who now works at the nonprofit Kiwanis Internatio­nal. She added

that customers are essentiall­y “held hostage” to pharmacies’ prices.

Prescripti­on drugs cost 14% more in San Francisco compared with the national average, making it the second most expensive U.S. city for prescripti­on medication­s, according to an analysis released Thursday by GoodRx, a website that tracks prescripti­on drug prices. Incidental­ly, in Indianapol­is, prescripti­on drugs cost 11% less than the national average, the report found.

GoodRx ranked the 30 most populous U.S. cities, identifyin­g the 10 most and 10 least expensive places for prescripti­on drugs. New York topped the former group, with costs 17% higher than the national average; Atlanta topped the latter, with costs 20% lower than the national average.

The report does not include a dollar figure for the national average.

The findings reflect the cash price for drugs — how much a patient would have to pay if they bought it at a pharmacy without insurance or discounts.

GoodRx, a Santa Monica company, analyzed insurance claims for the 500 most commonly prescribed prescripti­on drugs, including brand names and generics, in the 30 cities from April 2018 to March. Those drugs include atorvastat­in (for high cholestero­l), levothyrox­ine (for hypothyroi­dism) and lisinopril (for high blood pressure).

Tori Marsh, part of the GoodRx research team, which conducted the analysis, said it has not been determined why exactly prescripti­on drugs cost more in some cities than others, but there appears to be some correlatio­n between a city’s overall cost of living and the cost of drugs there.

Researcher­s also theorize that cities such as San Francisco that don’t have as many big-box retailers like Walmart, which often offer cheaper generic drugs, may see higher prices. Pharmacy markups are also a likely factor.

San Francisco was also the second most expensive city for prescripti­on drugs last year, when GoodRx did a similar analysis, with costs nearly 13% higher than the national average.

“This data highlights the nonsensica­l and variable nature of drug pricing,” Marsh wrote in a blog post on the 2018 findings, citing vast difference­s in costs even when comparing cities relatively close to one another, like Cleveland (2.5% higher than the national average) and Columbus (22% lower than the national average). “How is it that cities in the same state could have such wildly different pricing for prescripti­on drugs?”

Few other consumer goods vary so much in pricing for the exact some product — an inconsiste­ncy arising from the lack of transparen­cy and regulation in the drug pricing system, experts said. Drug manufactur­ers, pharmacy benefit managers and insurance companies negotiate among themselves to determine how much each will pay and receive for certain drugs, and those arrangemen­ts are considered proprietar­y.

This leads to major price difference­s not just city by city, but pharmacy by pharmacy

“This the nonsensica­l data highlights and variable nature of drug pricing.” Tori Marsh, GoodRx researcher

within the same few blocks, for the same drug. A recent study found that between 2011 and 2016, the prices set by 13 major drug manufactur­ers went up 15% each year, but the amount the manufactur­ers got back only went up 2.7% each year because much of the money went to intermedia­ries, the pharmacy benefit managers, said Dr. Kevin Schulman, a Stanford health economist and lead author of the study. The consumer is often paying the inflated price.

“There’s not a lot of transparen­cy at all in the market,” Schulman said. “Some of the times, the cash prices can be pretty outrageous. They may not at all be related to how much the product actually cost the pharmacy. You might go to your local pharmacy and see the cash price is $100 more than it was at Walmart” in the same area.

Lisa Kroon, a professor and chair of the Department of Clinical Pharmacy at the UCSF School of Pharmacy, said it’s important that consumers compare prices at multiple drugstores. Many pharmacy chains offer discounts or inexpensiv­e generics for common medicines treating diabetes and blood pressure for patients who don’t have insurance or whose insurance plan covers very little.

“Definitely shop around because you may call one pharmacy and another pharmacy might give you a different number,” she said.

If prescripti­ons are so costly that they are out of reach, patients can ask their doctor and pharmacist if there are any similar lower cost alternativ­es, such as a different pill strength, she said.

“Really talk to the pharmacist and don’t be afraid to say, ‘This cost is too prohibitiv­e; is there anything else?’ ” Kroon said. “Ask questions. We believe the role of the pharmacist, in addition to making sure people are on the right medication, is to help them be on the medicine they can actually afford and take because if they can’t afford it, they’re not going to take it.”

Newspapers in English

Newspapers from United States